Aveo says partner Astellas will not seek EU nod for kidney cancer drug

Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe.

http://www.reuters.com/article/2013/05/23/aveo-study-idUSL3N0E43YX20130523?feedType=RSS&feedName=rbssHealthcareNews